Jeong D, Cha H, Kim E, Kang M, Yang DK, Kim JM, et al
Although ACTL6A has been characterized as an oncogene in many human cancers, its role in GC is unknown, and knowledge of the underlying mechanisms is limited
Myo-inositol in the human body promotes the translocation of glucose transporter type 4 to the plasma membrane for glucose uptake and, in turn, reduces the release of free fatty acids
It supports the bodys antioxidant defence system and may help enhance the absorption of glutathione
185 In a clinical pilot trial on 14 advanced cancer patients, combined insulin/glucose infusions were therefore started at most 18 h before the administration of methotrexate/5FU